Skip to content

additional intervention for self-management in chronic pain patients

additional intervention for self-management in chronic pain patients - Agrippa

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON47980
Enrollment
150
Registered
2019-10-02
Start date
2019-09-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronische musculo-skeletale pijn chronic pain

Interventions

Agrippa app
Application on the smartphone with the content developed in an earlier study (SOLACE) based on general self-regulation principles with the aim of transferring crucial treatment insights to the patie

Sponsors

Hogeschool Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Chronic Pain Patients qualified for a intensive rehabilitation program in the secundary care defined as patient with a classification WPN 3 and 4 ( Werkgroep Pijnrevalidatie Nederland); social and psychological factors are complex to very complex and play an important role

Exclusion criteria

Exclusion criteria: Chronic pain patient not classified as WPN 3 or 4. Patients with specific complaints like rheumatoid arthritis, carcinoma, stroke etc

Design outcomes

Primary

MeasureTime frame
1) The degree of relapse, relapse is defined here as the patient's inability to retain the profit made in the area of daily functioning during rehabilitation. The Pain Disability Index and the Pain Self Efficacy Questionnaire (Van der Maas. 2012) from the Dutch Pain Rehabilitation Data Set are used as an outcome measure.

Secondary

MeasureTime frame
Fear avoidance beliefs (FABQ), Self efficacy (PSEQ), illness perception (IPQ-k) and psychological flexibility (PIPS) are viewed as mediators. In addition, healthcare consumption is monitored by completing a cost diary.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)